FDA Inspection 668085 — Immunovative Clinical Research, Inc.

Immunovative Clinical Research, Inc. — FEI 3008211589

The FDA completed an inspection of Immunovative Clinical Research, Inc. on June 10, 2010 in Carlsbad, CA. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). 2 citations were issued during this inspection. Product area: Biologics.

Inspection Details

Classification
Official Action Indicated (OAI) (OAI)
End Date
June 10, 2010
Fiscal Year
2010
Product Type
Biologics
Project Area
Bioresearch Monitoring
Location
Carlsbad, CA (United States)

Additional Details

Sponsor, Contract Research Organization

Citations

IDCFRDescription
741121 CFR 312.53(c)(1)Investigator statement (FDA 1572)
748021 CFR 312.50Ensuring compliance with plan and protocol